Federal government will no longer pay for heart transplants for Medicare patients at South Carolina hospital

Tim Casey | | Cardiovascular Business | Economics

The federal government will no longer pay to cover heart transplants for Medicare patients at Medical University Hospital in South Carolina, the Post and Courier reports.

The newspaper wrote that the government identified the hospital’s heart transplant program as low volume, but a hospital spokeswoman said the decision was based on old data.

The hospital is appealing the decision. It is the only hospital in South Carolina that performs heart transplant, according to the newspaper.

Read the full article below:

Medicare stops paying for heart transplants at MUSC

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Related Content

Johnson & Johnson MedTech faces threat of permanent injunction after losing antitrust case
Atraverse Medical raises $29M to support FDA-approved heart tech
Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B
Why more doctors should pursue business and leadership training
Medtronic’s diabetes spin-off gets a name, kicking off ‘new and exciting chapter’
Smaller revenues, less growth: In US, tariffs may create headaches for $34.5B cardiovascular device market

Around the web

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Radiology Business
U.S. iodine contrast supply may not be subject to proposed 25% tariffs

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.